BDBM704753 N-(3-(3,5-dimethylisoxaozl-4-yl)-4-(2-(pyrrolidin-1- yl)ethoxy)phenyl)-4-methylthiazole-5-carboxamide::US20240376090, Compound 109

SMILES Cc1ncsc1C(=O)Nc1ccc(OCCN2CCCC2)c(-c2c(C)noc2C)c1

InChI Key InChIKey=IDMVDPPCKDPWIW-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 704753   

Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM704753(N-(3-(3,5-dimethylisoxaozl-4-yl)-4-(2-(pyrrolidin-...)
Affinity DataKi:  3.78nMAssay Description:Radioligand binding assays were performed using [3H]5-HT as the radioligand using cell membranes prepared from HEK293 cells expressing recombinant 5-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/20/2025
Entry Details
US Patent